However, caution should be taken, as adverse CD-59 blockade may cause paroxysmal nocturnal hemoglobinuria (PNH), which is characterized by elevated complement activity, RBCs lysis and CD-59 decreased expression (59). The gene discussed is CD59; the disease is paroxysmal nocturnal hemoglobinuria.